Scinovex
article Open Access

Clinical study for validation of safety and efficacy of Laooq Khayar Shambar for symptomatic relief in Nazla (Common cold)

Z. A. SiddiquiMohd. ArshadNajm-us-SeharFasih AhmadMohd NaimeBarkat BariAmir -Jamal AkhtarMohd Nafees Khan

Abstract

Nazla, often referred to as common cold, acute viral rhinopharyngitis, nasopharyngitis, acute coryza, or just cold, is an upper respiratory tract viral infection that mostly affects the throat, nose, voice box and sinuses and is primarily caused by rhinoviruses and corona viruses. Nazla-o-Zukām is described in the literature of Unani medicine as a catarrhal fluid flow towards the throat and nose from the anterior ventricles of brain. At the Central Research Institute of Unani Medicine (CRIUM), Basaha, Lucknow, a clinical study was conducted from 2017 to 2019 to scientifically establish the safety as well as efficacy of the Unani pharmacopoeial formulation

Citations
0
FWCI
0.00
field-weighted impact
References
26
Percentile
2%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.